EVEROLIMUS ASSOCIATO A DOSI MOLTO BASSE DI CYA DETERMINA ELEVATO GFR RISPETTO AL TRATTAMENTO STANDARD AIDA LARTI E. Bertoni, G. Rosso, L. Di Maria, M.

Slides:



Advertisements
Presentazioni simili
“FIBROSI NEFROGENICA SISTEMICA”
Advertisements

Lino Mannocci Monotypes. She oil painting There were clouds in the sky.
DG Ricerca Ambientale e Sviluppo FIRMS' FUNDING SCHEMES AND ENVIRONMENTAL PURPOSES IN THE EU STRUCTURAL FUNDS (Monitoring of environmental firms funding.
IL MONITORAGGIO EMODINAMICO NELLO SCOMPENSO CARDIACO
Basi farmacologiche della terapia dell’ipertensione
Diversity in Europe Queste nazioni hanno in comune a due a due, tre colori molto importanti: Il colore verde indica la speranza; The green color points.
SECONDA CONFERENZA DEI PROGETTI DEL CENTRO FERMI APRILE 2012 SALONE DELLE CONFERENZE DEL MINISTERO DELLINTERNO ROMA, PIAZZA DEL VIMINALE 1 In vitro-In.
Each meeting was an opportunity to pause; to listen and to find God in the quiet. Ogni incontro si è presentato come un'opportunità per ascoltare, riflettere.
Faculty of Medicine and Psychology University of Rome “La Sapienza”
MA.RE.A. L’IMPORTANZA DEL FATTORE TEMPO Novara, 14 maggio 2013
CMS RPC R&D for phase 2 Two types of upgrades proposed for the CMS RPC muon system: 1.Aging and longevity: installed in 2007, must continue to operate.
Results of the AIEOP AML 2002/01 multicenter prospective trial for the treatment of children with acute myeloid leukemia by Andrea Pession, Riccardo Masetti,
PINK FLOYD DOGS You gotta be crazy, you gotta have a real need. You gotta sleep on your toes. And when you're on the street. You gotta be able to pick.
CMS RPC R&D for phase 2 Two types of upgrades proposed for the CMS RPC muon system: 1.Aging and longevity: installed in 2007, must continue to operate.
Sicily (Italian and Sicilian: Sicilia) is an autonomous region of Italy in Europe. Of all the regions of Italy, Sicily covers the largest surface.
Go, A. S. et al. JAMA 2001;285: La combinazione antitrombotica appropriata nel paziente con fibrillazione atriale e indicazione alla TAO sottoposto.
Clinical performance of serum isoform [-2]proPSA (p2PSA) and its derivatives, namely %p2PSA and PHI (Prostate Health Index) in men younger than 60 years.
Minimal Emergence of Darunavir Resistance at Treatment Failure: Are Interpretation Algorithms Adequate? Gaetana Sterrantino* 1, Mauro Zaccarelli 2, Maurizio.
Aggiornamento attivita’ gruppo Windows Gian Piero Siroli, Dip. di Fisica, Università di Bologna e INFN CCR, ottobre 2007.
Organizzazione e Formazione per l’arresto cardiaco in ospedale Overview Epidemiologia dell’ arresto intraospedaliero Criticita’ organizzative Applicazioni.
Advanced EC – Study on Cytoreductive Surgery
XXIX^ Riunione Nazionale MITO – Sessione Data Manager 21 Giugno 2017
The MITO-16/MANGO-OV2 Project: 8th Progress Report
List of the Ethics’ Committees and respective centers
Lucia Del Mastro Gruppo Italiano Mammella - GIM Napoli 10 marzo 2017
RISPOSTA VIROLOGICA NEI CAMBI DI TERAPIA IN PAZIENTI COINFETTI CON HCV CON HIV-RNA NON RILEVABILE NEI QUALI SI PASSA AD UNA TERAPIA CHE INCLUDE RAL A PARTIRE.
Incidence Of Atrial Fibrillation In Mitral Valve Repair Versus Replacement In Elderly Patients F. Pollari1, M. Fittipaldi1, M. Cuomo1, M. Lusini1, M. Chello1,
ACC / AHA Guidelines STAGE A: Pazienti ad alto rischio di sviluppare disfunzione ventricolare sinistra STAGE B: Pazienti con disfunzione ventricolare sinistra.
American Heart Journal
Daniele Pedrini INFN Milano-Bicocca
2013 ACC/AHA Guidelines Treatment of Blood Cholesterol to Reduce Atherosclerotic Cardiovascular Risk in Adults.
Enzo Palmieri ISTITUTO NAZIONALE DI FISICA NUCLEARE
Supporto statistico online
PROGETTO SPARC: RISULTATI RECENTI ED ATTIVITA’ PER IL 2012
Volume 126, Issue 5, Pages (November 2004)
NON MUSCOLAR INVASIVE BLADDER CANCER IN YOUNG PATIENTS BEFORE 30 YEARS: PROGNOSTIC FACTORS AND OUTCOME A. Salerno, S. Gerocarni Nappo, V. Pagliarulo, F.
Fig. 7. Dominant negative HNF-4 is able to rescue the estrogen inducibility of native FXII promoter by counteracting endogenous HNF-4. Native FXII promoter.
Heart failure and anemia: Effects on prognostic variables
Highlights del meeting ESPP di Cracovia Settembre 2012 (FISICA DI G1)
A Cytologic Assay for Diagnosis of Food Hypersensitivity in Patients With Irritable Bowel Syndrome  Antonio Carroccio, Ignazio Brusca, Pasquale Mansueto,
La dose di MMF post-trapianto influenza la funzione renale: analisi preliminare del database MOST M. Salvadori, G. Corbetta On behalf of the MOST Database.
Primary end points -evaluation of safety in terms of:
Marzo 2018.
An open-label, pilot study of fludarabine, cyclophosphamide, and alemtuzumab in relapsed/refractory patients with B-cell chronic lymphocytic leukemia by.
Utility of baseline 18FDG-PET/CT functional parameters in defining prognosis of primary mediastinal (thymic) large B-cell lymphoma by Luca Ceriani, Maurizio.
Bendamustine, Low-Dose Dexamethasone, and Lenalidomide (BdL) For The Treatment Of Patients With Relapsed Multiple Myeloma Confirms Very Promising Results.
Il Progetto EXTRA.
INFN, Legnaro (PD) 24 gennaio 2006
Firenze italia (Florence italy)
Safety for Patients With Celiac Disease of Baked Goods Made of Wheat Flour Hydrolyzed During Food Processing  Luigi Greco, Marco Gobbetti, Renata Auricchio,
High risk coronary artery bypass patient: incidence, surgical strategies, and results  Mario Gaudino, MD, Franco Glieca, MD, Francesco Alessandrini, MD,
A Cytologic Assay for Diagnosis of Food Hypersensitivity in Patients With Irritable Bowel Syndrome  Antonio Carroccio, Ignazio Brusca, Pasquale Mansueto,
Oggi è lunedì il nove dicembre 2013
Diagnostic Performance of Low-Dose Computed Tomography Screening for Lung Cancer over Five Years  Giulia Veronesi, MD, Patrick Maisonneuve, DipEng, Lorenzo.
Trattamento lesioni sopra e sotto il ginocchio:
Highlight 2017 TUMORI GENITOURINARI
Lanosterol Synthase Genetic Variants, Endogenous Ouabain, and Both Acute and Chronic Kidney Injury  Rossella Iatrino, Chiara Lanzani, Elena Bignami, Nunzia.
A randomized study on eversion versus standard carotid endarterectomy: Study design and preliminary results: The Everest Trial  Piergiorgio Cao, MD, Giuseppe.
Preliminary results of endovascular aneurysm sealing from the multicenter Italian Research on Nellix Endoprosthesis (IRENE) study  Bruno Gossetti, MD,
HCV.
QUESTIONARIO PER PROFESSORI QUESTIONNAIRE FOR TEACHERS
CdS 2017: embargo fino a TAUP2017
Is there a role for soy isoflavones in the therapeutic approach to polycystic ovary syndrome? Results from a pilot study  Daniela Romualdi, M.D., Barbara.
MITO 31 A phase II trial of Olaparib in patients with recurrent ovarian cancer wild type for germline and somatic BRCA mutations: a MITO translational.
High-Dose Melphalan Plus Thiotepa as Conditioning Regimen before Second Autologous Stem Cell Transplantation for “De Novo” Multiple Myeloma Patients:
Integrazione di dati provenienti da più fonti
Gastrointestinal Endoscopy
Wikipedia Wikipedia è un'enciclopedia online, collaborativa e libera. Grazie al contributo di volontari da tutto il mondo, Wikipedia ad ora è disponibile.
Age-sex–specific ranges of platelet count and all-cause mortality: prospective findings from the MOLI-SANI study by Marialaura Bonaccio, Augusto Di Castelnuovo,
Group B – Gucci profile part II
Transcript della presentazione:

EVEROLIMUS ASSOCIATO A DOSI MOLTO BASSE DI CYA DETERMINA ELEVATO GFR RISPETTO AL TRATTAMENTO STANDARD AIDA LARTI E. Bertoni, G. Rosso, L. Di Maria, M. Zanazzi and M. Salvadori Renal Unit Careggi University Hospital – Florence ,Italy

AIM OF THE STUDY PATIENTS AND METHODS Aim of the study was to compare in cadaveric renal transplant recipients the efficacy of CyA “very low dose” with Everolimus “high dose” with respect to CyA “standard dose” with EC-MPS PATIENTS AND METHODS In a randomized, prospective, monocenter, open study, 106 patients were enrolled to receive : 56 pts : Everolimus (to reach C0 8-10 ng/ml) + CyA (to reach C2 250-300 ng/ml ) + steroids 50 pts : EC-MPS (1440 mg/day) + Cya (to reach C2 500-700 ng/ml) + steroids - Efficacy was evaluated at 3 and 12 months - Data analyses have been made per protocol Efficacy was evaluated at 3 and 12 months. Data analyses have been made per protocol

RESULTS I

RESULTS II

RESULTS